These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 11938457)

  • 1. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
    Mautino MR; Morgan RA
    Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
    Plavec I; Agarwal M; Ho KE; Pineda M; Auten J; Baker J; Matsuzaki H; Escaich S; Bonyhadi M; Böhnlein E
    Gene Ther; 1997 Feb; 4(2):128-39. PubMed ID: 9081703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
    Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 replication by combined expression of gag dominant negative mutant and a human ribonuclease in a tightly controlled HIV-1 inducible vector.
    Cara A; Rybak SM; Newton DL; Crowley R; Rottschafer SE; Reitz MS; Gusella GL
    Gene Ther; 1998 Jan; 5(1):65-75. PubMed ID: 9536266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
    Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
    Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the effect of the combined expression of anti-tat and anti-rev genes on HIV-1 replication.
    Caputo A; Rossi C; Bozzini R; Betti M; Grossi MP; Barbanti-Brodano G; Balboni PG
    Gene Ther; 1997 Apr; 4(4):288-95. PubMed ID: 9176513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy.
    Duan L; Zhu M; Ozaki I; Zhang H; Wei DL; Pomerantz RJ
    Gene Ther; 1997 Jun; 4(6):533-43. PubMed ID: 9231069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
    Peng H; Callison D; Li P; Burrell C
    Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
    Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
    Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV-1 by a double transdominant fusion gene.
    Aguilar-Cordova E; Chinen J; Donehower LA; Harper JW; Rice AP; Butel JS; Belmont JW
    Gene Ther; 1995 May; 2(3):181-6. PubMed ID: 7614248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells.
    Liu J; Woffendin C; Yang ZY; Nabel GJ
    Gene Ther; 1994 Jan; 1(1):32-7. PubMed ID: 7584057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
    Natarajan V; Radjendirane V; Salzman NP
    Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
    Chang LJ; Liu X; He J
    Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
    Junker U; Böhnlein E; Veres G
    Gene Ther; 1995 Nov; 2(9):639-46. PubMed ID: 8548553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics.
    Ragheb JA; Bressler P; Daucher M; Chiang L; Chuah MK; VandenDriessche T; Morgan RA
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1343-53. PubMed ID: 8573391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced inhibition of human immunodeficiency virus type 1 replication by novel lentiviral vectors expressing human immunodeficiency virus type 1 envelope antisense RNA.
    Mautino MR; Morgan RA
    Hum Gene Ther; 2002 Jun; 13(9):1027-37. PubMed ID: 12067436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved titers of HIV-based lentiviral vectors using the SRV-1 constitutive transport element.
    Mautino MR; Keiser N; Morgan RA
    Gene Ther; 2000 Aug; 7(16):1421-4. PubMed ID: 10981670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.